Apollo Hospitals Q4 Results: Profit Rises 54%, Meets Estimates
Revenue rises 13% to Rs 5,592 crore in the quarter ended March.
Apollo Hospitals Enterprise Ltd.'s consolidated net profit increased by 53.5% in the fourth quarter of the financial year 2025, meeting analysts' estimates.
The company posted a bottom line of Rs 390 crore in the quarter ended March 31, 2025, according to an exchange filing on Friday. Analysts tracked by Bloomberg had estimated a profit of Rs 374 crore.
Apollo Hospitals Q4 Highlights (Consolidated, YoY)
Revenue up 13% at Rs 5,592 crore versus Rs 4,944 crore (Bloomberg estimate: Rs 5,620 crore)
Ebitda up 20% at Rs 770 crore versus Rs 641 crore (Estimate: Rs 785 crore)
Ebitda margin at 13.8% versus 13% (Estimate: 14%)
Net profit up 53.5% at Rs 390 crore versus Rs 254 crore (Estimate: Rs 374 crore)
The company's board has recommended a final dividend of Rs 10 per equity share of the face value of Rs 5 per share to the shareholders of the company for fiscal year 2024-25, as per an exchange filing.
The dividend recommended by the board is subject to shareholder approval at the ensuing Annual General Meeting of the company.
The board has fixed the record date as Aug. 18 for the purpose of determining the names of the shareholders who are entitled for the final dividend. The dividend, if declared at the AGM, will be paid on or before Sept. 10, 2025.
The board had also declared an interim dividend of Rs 9 per equity share on Feb. 10, which was paid to the eligible shareholders on Feb. 28.
"FY25 was a defining year. With revenues crossing Rs 20,000 crore and Healthcare Services surpassing Rs11,000 crore, we are humbled by the trust placed in us across India and beyond," said Prathap C Reddy, chairperson of Apollo Hospitals Enterprise.
The board has also approved the re-appointment of executive directors —Preetha Reddy, executive vice chairperson; Suneeta Reddy, managing director; and Sangita Reddy, joint managing director — for a further period of five years with effect from Feb. 3, 2026, subject to approval of members at the ensuing AGM.
The company also approved Som Mittal as an independent director of the company, whose first five-year term as an independent director expires on July 20, 2026.
Shares of Apollo Hospitals closed 0.68% lower at Rs 6,878.2 apiece on the BSE, compared to a 0.22% decline in the benchmark Sensex, before the quarterly results were declared.
